New Mexico Settles for $2.25 Million Over EpiPen Pricing Dispute

The New Mexico Attorney General, Raúl Torrez, announced a $2.25 million settlement with Mylan Inc. regarding allegations of unfair and anticompetitive practices related to EpiPen Auto-Injectors. The settlement addresses claims that Mylan's pricing strategies violated state consumer protection and antitrust laws. Although Mylan denied any wrongdoing, the agreement will fund investigation costs and health care initiatives, while also increasing co-pay coupons for generic EpiPens. Furthermore, Mylan will donate up to 10,000 EpiPens to New Mexico schools over the next four years, aiming to enhance access to this critical allergy treatment.

Key Details: • Settlement amount: $2.25 million • Mylan will donate 10,000 EpiPens to schools over four years • Co-pay coupon for generic EpiPen increased from $35 to $40 • Collaboration to raise awareness about free EpiPen programs for schools